Biophytis S.A. BPTSY
0.50 USD 0.00 (+0.00%)
At closeFeb 5, 2026, 4:00 PM EST
1.38 Day range 1.38
0.001 52-week range 2.00
- YTD
- +4,445.45%
- 1 year
- -82.01%
News
newsfilecorp.com Biophytis Targets Mobility Restoration in Patients with Obesity Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - April 22, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in…
newsfilecorp.com Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - April 9, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the…
newsfilecorp.com Biophytis Announces New Non-Clinical Data Further Supporting Its Mission to Pioneer the Restoration of Mobility in Patients with Obesity 96% of patients with obesity report experiencing muscle strength impairment, affecting their mobility New preclinical study results: The combination of BIO101 and GLP-1 induced muscle strength and…
newsfilecorp.com Biophytis Revolutionizes Sarcopenia Publication of SARA-INT Phase II results for BIO101 Confirmation of Phase 3 readiness Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - March 17, 2025) - Biophytis SA (FP: ALBPS)…
newsfilecorp.com Biophytis Announces its Participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR) Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - February 25, 2025) - Biophytis SA (FP: ALBPS) ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the…
newsfilecorp.com Biophytis Unveils Its Outlook Strategies for 2025 Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - February 11, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the…
newsfilecorp.com Biophytis Announces Its Participation to the BIOMED FORUM Investor Conference Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - January 27, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the…
newsfilecorp.com Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - January 21, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the…